AHEAD OF DISEASE TOGETHER
DEAD

Serial Number

90790752

Owner

SMITHKLINE BEECHAM LIMITED

Attorney

Christopher M. Hanes

Filing Date

Jun 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

AHEAD OF DISEASE TOGETHER Trademark

Serial Number: 90790752

AHEAD OF DISEASE TOGETHER is a trademark filed by SMITHKLINE BEECHAM LIMITED on June 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

SMITHKLINE BEECHAM LIMITED (177 trademarks)

980 GREAT WEST ROAD
BRENTFORD, MIDDLESEX TW8 9GS , GB

Entity Type: 11

Trademark Details

Filing Date

June 23, 2021

Registration Date

Not Registered

Published for Opposition

May 24, 2022

Goods & Services

Education services, namely, providing live and on-line lectures, seminars, and conferences relating to pharmaceutical, diagnostic, vaccines, propriety medicines, health and medical industries; Organization of exhibitions for cultural or educational purposes

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Promotional and advertising services; Providing advertising and promotional services for the pharmaceutical and medical industry online, via cable and/or the Internet; The provision of consumer information for customers on pharmaceutical, medical, and healthcare products through an on-line computer network

Health care services; Provision of medical information and medical services; Providing medical information to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments via the Internet; Gene and cell therapy being medical services

Surgical apparatus for medical use

Scientific research for medical purposes in the field of pharmaceutical, vaccines, cell and gene therapy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 25, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 25, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 27, 2025 EXRA
SOU EXTENSION 5 GRANTED
Mar 26, 2025 EX5G
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2025 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 26, 2025 AITU
SOU EXTENSION 5 FILED
Dec 6, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 6, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 23, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 23, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 23, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jul 10, 2024 EX4G
SOU EXTENSION 4 FILED
Jul 10, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 10, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2024 EXRA
SOU EXTENSION 3 GRANTED
Jan 4, 2024 EX3G
SOU EXTENSION 3 FILED
Jan 4, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 14, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 14, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 14, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 13, 2022 EXRA
SOU EXTENSION 1 GRANTED
Sep 9, 2022 EX1G
SOU EXTENSION 1 FILED
Sep 9, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 9, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 2, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 2, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 19, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 19, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 22, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
NEW APPLICATION ENTERED
Jun 26, 2021 NWAP